Actively Recruiting
The Associations Between EIT and Clinical Measures During Standard of Care Procedures in Patients With Respiratory Disease: A Preliminary Study
Led by University of Colorado, Denver · Updated on 2025-11-13
90
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the Genesis Electrical Impedance Tomography (EIT) imaging system to understand its use in children and adults with respiratory diseases like neuromuscular disorders and bronchopulmonary dysplasia, as well as in healthy individuals matched by age and height. This study aims to assess how EIT, which uses electrodes and does not involve radiation, can detect changes in lung ventilation during various pulmonary treatments. The study includes different groups such as premature infants with bronchopulmonary dysplasia, children and adults with neuromuscular diseases, healthy controls, and patients undergoing specific heart and lung procedures like V/Q scans and cardiac catheterization. Researchers will use EIT imaging to observe lung function changes related to airway clearance and both invasive and noninvasive ventilation. Some participants will be followed longitudinally, especially premature infants. Participants will undergo EIT imaging during standard care procedures, with assessments of regional lung ventilation and perfusion over time, including measurements taken within minutes and over 24 months. The study collects data on lung conductivity and pulsatile perfusion, and tracks changes related to breathing and blood flow. The research team will monitor these measures to better understand lung function in these populations, with study participation possibly lasting up to two years.
CONDITIONS
Brief Title
Genesis Electrical Impedance Tomography (EIT): A Preliminary Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 2 weeks and 40 years
- Premature infants older than 2 weeks with confirmed bronchopulmonary dysplasia based on NIH criteria
- Chronic respiratory disease due to underlying neuromuscular disease
- Confirmed neuromuscular disease with echocardiogram done within the last 12 months for Duchenne muscular dystrophy or similar diagnoses
- Have had a ventilation/perfusion (V/Q) scan
- Undergoing cardiac catheterization for pulmonary vein stenosis, pulmonary hypertension, or pulmonary artery stenosis
- Healthy controls matched by age and height
You will not qualify if you...
- Younger than 2 weeks of age
- Congenital diaphragmatic hernia
- Severe congenital heart disease
- Significant genetic abnormalities
- Conditions that interfere with electrode placement on the chest
- Unwilling or refusal to sign consent
- Pregnant or lactating
- Presence of pacemaker, surgical implant, or spinal implant causing data noise
- Moderate to severe cardiomyopathy
- Temporary cognitive disability due to illness
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 24 months
Participants undergo Electrical Impedance Tomography (EIT) imaging and other clinical assessments during standard care procedures to evaluate lung ventilation and perfusion.
Visits aligned with routine clinical procedures; frequency varies by participant cohort
Duration - Up to 24 months
Participants are monitored over time to track changes in lung function and regional ventilation using EIT.
Ongoing assessments during clinical care visits as applicable
Trial Site Locations
Total: 1 location
1
Children's Hospital Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
Research Team
E
Emily DeBoer, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here